Cite
HARVARD Citation
Saxena, K. et al. (2021). A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer. 127 (20), pp. 3761-3771. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Saxena, K. et al. (2021). A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer. 127 (20), pp. 3761-3771. [Online].